208 related articles for article (PubMed ID: 30276400)
1. Synthesis of heterobimetallic gold(i) ferrocenyl-substituted 1,2,3-triazol-5-ylidene complexes as potential anticancer agents.
Aucamp D; Kumar SV; Liles DC; Fernandes MA; Harmse L; Bezuidenhout DI
Dalton Trans; 2018 Nov; 47(45):16072-16081. PubMed ID: 30276400
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of Pyrazine-Based Cyclometalated (C^N
Bertrand B; Fernandez-Cestau J; Angulo J; Cominetti MMD; Waller ZAE; Searcey M; O'Connell MA; Bochmann M
Inorg Chem; 2017 May; 56(10):5728-5740. PubMed ID: 28441013
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold(I) complexes.
De Nisi A; Bergamini C; Leonzio M; Sartor G; Fato R; Naldi M; Monari M; Calonghi N; Bandini M
Dalton Trans; 2016 Jan; 45(4):1546-53. PubMed ID: 26687209
[TBL] [Abstract][Full Text] [Related]
4. Carbene transfer from triazolylidene gold complexes as a potent strategy for inducing high catalytic activity.
Canseco-Gonzalez D; Petronilho A; Mueller-Bunz H; Ohmatsu K; Ooi T; Albrecht M
J Am Chem Soc; 2013 Sep; 135(35):13193-203. PubMed ID: 23902160
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of gold(I) phosphine complexes containing the 2-BrC
Reddy TS; Privér SH; Mirzadeh N; Bhargava SK
Eur J Med Chem; 2018 Feb; 145():291-301. PubMed ID: 29331752
[TBL] [Abstract][Full Text] [Related]
6. Heteronuclear gold(I)-silver(I) sulfanylcarboxylates: Synthesis, structure and cytotoxic activity against cancer cell lines.
Barreiro E; Casas JS; Couce MD; Sánchez A; Sordo J; Vázquez-López EM
J Inorg Biochem; 2014 Feb; 131():68-75. PubMed ID: 24269769
[TBL] [Abstract][Full Text] [Related]
7. In vitro anticancer activity of gold(III) complexes with some esters of (S,S)-ethylenediamine-N,N'-di-2-propanoic acid.
Pantelić N; Stanojković TP; Zmejkovski BB; Sabo TJ; Kaluđerović GN
Eur J Med Chem; 2015 Jan; 90():766-74. PubMed ID: 25528331
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives.
Wang S; Shao W; Li H; Liu C; Wang K; Zhang J
Eur J Med Chem; 2011 May; 46(5):1914-8. PubMed ID: 21392862
[TBL] [Abstract][Full Text] [Related]
9. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
Liu W; Bensdorf K; Proetto M; Abram U; Hagenbach A; Gust R
J Med Chem; 2011 Dec; 54(24):8605-15. PubMed ID: 22091836
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates.
Lemke J; Pinto A; Niehoff P; Vasylyeva V; Metzler-Nolte N
Dalton Trans; 2009 Sep; (35):7063-70. PubMed ID: 20449149
[TBL] [Abstract][Full Text] [Related]
11. Comparative biological evaluation and G-quadruplex interaction studies of two new families of organometallic gold(I) complexes featuring N-heterocyclic carbene and alkynyl ligands.
Meier-Menches SM; Aikman B; Döllerer D; Klooster WT; Coles SJ; Santi N; Luk L; Casini A; Bonsignore R
J Inorg Biochem; 2020 Jan; 202():110844. PubMed ID: 31739113
[TBL] [Abstract][Full Text] [Related]
12. Gold complexes with benzimidazole derivatives: synthesis, characterization and biological studies.
Mota VZ; de Carvalho GS; da Silva AD; Costa LA; de Almeida Machado P; Coimbra ES; Ferreira CV; Shishido SM; Cuin A
Biometals; 2014 Feb; 27(1):183-94. PubMed ID: 24442571
[TBL] [Abstract][Full Text] [Related]
13. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF
J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390
[TBL] [Abstract][Full Text] [Related]
15. Gold amides as anticancer drugs: synthesis and activity studies.
Newcombe S; Bobin M; Shrikhande A; Gallop C; Pace Y; Yong H; Gates R; Chaudhuri S; Roe M; Hoffmann E; Viseux EM
Org Biomol Chem; 2013 May; 11(19):3255-60. PubMed ID: 23584015
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of gold(III) complexes on A549 human lung carcinoma epithelial cell line.
Arsenijević M; Milovanovic M; Volarevic V; Djeković A; Kanjevac T; Arsenijević N; Dukić S; Bugarcić ZD
Med Chem; 2012 Jan; 8(1):2-8. PubMed ID: 22420544
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of AuNPs by monofunctional triazole linked to ferrocene, ferricenium, or coumarin and applications to synthesis, sensing, and catalysis.
Li N; Zhao P; Igartua ME; Rapakousiou A; Salmon L; Moya S; Ruiz J; Astruc D
Inorg Chem; 2014 Nov; 53(21):11802-8. PubMed ID: 25363304
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lipoxygenase (LOX) and anticancer activity caused by gold(I) mixed ligands complexes of triphenylphosphine and thioamides.
Georgiou E; Metsios A; Kourkoumelis N; Karkabounas S; Charalabopoulos K; Badeka A; Hadjikakou SK
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):592-7. PubMed ID: 21087193
[TBL] [Abstract][Full Text] [Related]
19. A Gold(III) Pincer Ligand Scaffold for the Synthesis of Binuclear and Bioconjugated Complexes: Synthesis and Anticancer Potential.
Bertrand B; O'Connell MA; Waller ZAE; Bochmann M
Chemistry; 2018 Mar; 24(14):3613-3622. PubMed ID: 29334159
[TBL] [Abstract][Full Text] [Related]
20. The fluxional amine gold(III) complex as an excellent catalyst and precursor of biologically active acyclic carbenes.
Montanel-Pérez S; Herrera RP; Laguna A; Villacampa MD; Gimeno MC
Dalton Trans; 2015 May; 44(19):9052-62. PubMed ID: 25893402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
